By way of derogation from Part A of the Annex to Implementing Regulation (EU) No 540/2011, the following expiry dates shall apply:
(1)
31 July 2016, as regards the active substances: ethofumesate (entry 29), imazamox (entry 41), oxasulfuron (entry 42), ethoxysulfuron (entry 43), foramsulfuron (entry 44), oxadiargyl (entry 45), cyazofamid (entry 46), linuron (entry 51), pendimethalin (entry 53), trifloxystrobin (entry 59), carfentrazone ethyl (entry 60), mesotrione (entry 61), fenamidone (entry 62), isoxaflutole (entry 63) and warfarin (entry 120);
(2)
31 October 2016, as regards the active substances: deltamethrin (entry 40), 2,4-DB (entry 47), beta-cyfluthrin (entry 48), cyfluthrin (entry 49), iprodione (entry 50), maleic hydrazide (entry 52), flurtamone (entry 64), flufenacet (entry 65), iodosulfuron (entry 66), dimethenamid-P (entry 67), picoxystrobin (entry 68), fosthiazate (entry 69), silthiofam (entry 70) and Coniothyrium minitans Strain CON/M/91-08 (DSM 9660) (entry 71);
(3)
31 January 2017, as regards the active substances: propineb (entry 54), propyzamide (entry 55), mecoprop (entry 56), mecoprop-P (entry 57), propiconazole (entry 58), mesosulfuron (entry 75), propoxycarbazone (entry 76), zoxamide (entry 77), benzoic acid (entry 79), flazasulfuron (entry 80) and pyraclostrobin (entry 81).